Stay updated with breaking news from Analytical Reference Standards. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pervasip (OTCMKTS:PVSP – Get Free Report) and ChromaDex (NASDAQ:CDXC – Get Free Report) are both small-cap utilities companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, institutional ownership, earnings and risk. Volatility & Risk Pervasip has a beta of 0.21, […]
ChromaDex (NASDAQ:CDXC – Get Free Report) had its price objective hoisted by stock analysts at Roth Mkm from $4.25 to $6.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Roth Mkm’s price objective points to a potential upside of 44.58% […]
ChromaDex (NASDAQ:CDXC – Get Free Report) and FitLife Brands (NASDAQ:FTLF – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership. Profitability This table compares ChromaDex and FitLife Brands’ […]
ChromaDex Co. (NASDAQ:CDXC – Get Free Report) shares passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $1.66 and traded as high as $3.95. ChromaDex shares last traded at $3.95, with a volume of 346,416 shares traded. Analyst Upgrades and Downgrades […]
StockNews.com upgraded shares of ChromaDex (NASDAQ:CDXC – Free Report) from a buy rating to a strong-buy rating in a research note released on Friday morning. ChromaDex Stock Performance CDXC stock opened at $1.62 on Friday. The company’s 50 day moving average is $1.47 and its 200 day moving average is $1.45. The stock has a […]